PubRank

Steven R Levine

Author PubWeight™ 106.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 12.92
2 Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 7.92
3 Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010 6.93
4 Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006 4.21
5 National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 2006 2.82
6 A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke 2009 2.74
7 Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 2002 2.71
8 Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke 2009 2.26
9 Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006 1.73
10 Streamlining of prehospital stroke management: the golden hour. Lancet Neurol 2013 1.69
11 Microvascular brain pathology and late-life motor impairment. Neurology 2013 1.64
12 Emotional neglect in childhood and cerebral infarction in older age. Neurology 2012 1.50
13 Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 2005 1.48
14 Thrombolytic utilization for ischemic stroke in US hospitals with neurology residency program. Neurology 2013 1.44
15 The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med 2005 1.44
16 Virtual TeleStroke support for the emergency department evaluation of acute stroke. Acad Emerg Med 2004 1.39
17 Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke 2010 1.35
18 Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial. Stroke 2010 1.22
19 Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology 2013 1.17
20 Postpartum eclampsia complicated by reversible cerebral herniation. Obstet Gynecol 2006 1.15
21 Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke 2013 1.11
22 Failure of antithrombotic therapy and risk of stroke in patients with symptomatic intracranial stenosis. Stroke 2008 1.11
23 A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke. J Stroke Cerebrovasc Dis 2008 1.11
24 Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke 2006 1.10
25 Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke 2013 1.08
26 Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials. Stroke 2009 1.07
27 Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis 2008 1.07
28 Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med 2006 1.06
29 Emergency physician and stroke specialist beliefs and expectations regarding telestroke. Stroke 2010 1.00
30 Recognition and management of stroke in young adults and adolescents. Neurology 2013 0.98
31 In acute ischemic stroke, are asymptomatic intracranial hemorrhages clinically innocuous? Stroke 2004 0.97
32 Telestroke 10 years later--'telestroke 2.0'. Cerebrovasc Dis 2009 0.95
33 Alteplase for ischaemic stroke--much sooner is much better. Lancet 2010 0.94
34 Asymptomatic hemorrhagic transformation of cerebral infarction does not worsen long-term outcome. J Stroke Cerebrovasc Dis 2007 0.90
35 Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med 2010 0.90
36 Prediction of hospital disposition after thrombolysis for acute ischemic stroke using the National Institutes of Health Stroke Scale. Arch Neurol 2004 0.90
37 Stroke knowledge and barriers to stroke prevention among African Americans: implications for health communication. J Health Commun 2003 0.88
38 Proof of concept study: relating infarct location to stroke disability in the NINDS rt-PA trial. Cerebrovasc Dis 2013 0.87
39 Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke 2009 0.86
40 Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study. Neuroepidemiology 2002 0.86
41 Mild stroke and rapidly improving symptoms: it's not always a happy ending. Stroke 2011 0.85
42 Addressing racial and ethnic disparities in stroke: the time is now. Neurology 2006 0.85
43 Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke 2013 0.84
44 The cost-effectiveness of primary stroke centers for acute stroke care. Stroke 2012 0.84
45 Effectiveness of stroke education in the emergency department waiting room. J Stroke Cerebrovasc Dis 2010 0.84
46 Factors related to the sensitivity of emergency medical service impression of stroke. Prehosp Emerg Care 2014 0.83
47 Improved quality of stroke care for hospitalized Medicare beneficiaries in Michigan. Stroke 2005 0.83
48 Capturing the scope of stroke: silent, whispering, and overt. Arch Neurol 2009 0.82
49 Telemedicine for acute stroke: when virtual is as good as reality. Neurology 2007 0.80
50 Do gender and race impact the use of antithrombotic therapy in patients with stroke/TIA? Neurology 2004 0.80
51 Telestroke, QALYs, and current health care policy: the Heisenberg uncertainty principle. Neurology 2011 0.79
52 HandiStroke: a handheld tool for the emergent evaluation of acute stroke patients. Acad Emerg Med 2003 0.79
53 Dosing errors did not have a major impact on outcome in the NINDS t-PA stroke study. J Stroke Cerebrovasc Dis 2010 0.79
54 Is asymptomatic hemorrhagic transformation really innocuous? Neurology 2012 0.78
55 Comparison of short-term outcomes of thrombolysis for in-hospital stroke and out-of-hospital stroke in United States. Stroke 2013 0.78
56 Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology 2012 0.78
57 Smoke without fire: the complex effects of cigarette smoking on thrombolytic therapy for acute ischemic stroke. Neurology 2005 0.78
58 Lessons from adult stroke trials. Pediatr Neurol 2006 0.77
59 Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio. Cerebrovasc Dis 2015 0.77
60 The Continued Promise of Neuroprotection for Acute Stroke Treatment. J Exp Stroke Transl Med 2008 0.77
61 Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey. J Stroke Cerebrovasc Dis 2007 0.76
62 Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience. J Stroke Cerebrovasc Dis 2010 0.76
63 Optimizing an individual's treatment in acute stroke: is a magnetic resonance map leading us towards the holy grail? J Neurol Sci 2004 0.76
64 Acute ischemic stroke in hospitalized medicare patients: evaluation and treatment. Stroke 2003 0.76
65 A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke. Lancet Neurol 2010 0.75
66 A web-based interactive database system for a transcranial Doppler ultrasound laboratory. J Neuroimaging 2006 0.75
67 Is telemedicine the answer for delivering stroke care to rural areas? Nat Clin Pract Neurol 2007 0.75
68 Potassium depletion as a risk factor for stroke: will a banana a day keep your stroke away? Neurology 2002 0.75
69 The A's and B's of the ABC's of stroke mechanisms and recurrence in pediatric ischemic stroke. Neurology 2012 0.75
70 aPL and stroke in young women: more fuel for the stroke risk fire. Stroke 2002 0.75
71 Reversible cerebral vasoconstriction syndrome: a rose by any other name? Arch Neurol 2011 0.75
72 Spontaneous cervical artery dissection: is there a gender innuendo? Neurology 2006 0.75
73 Antiphospholipid antibodies: pinning risk on a moving target. Lancet Neurol 2009 0.75
74 The interplay of age, access to health care, and insurance status: the good, the bad, and the ugly. Arch Neurol 2007 0.75
75 The "almost magical" mobile stroke unit revolution. Neurology 2012 0.75
76 Targeting ischemic penumbra Part II: selective drug delivery using liposome technologies. J Exp Stroke Transl Med 2011 0.75
77 Thrombophilias and stroke: diagnosis, treatment, and prognosis. J Thromb Thrombolysis 2005 0.75
78 Safer thrombolysis for acute ischemic stroke: is early recanalization the key? Neurology 2008 0.75
79 The time man has cometh to brain: tick...death....tick...death. Stroke 2005 0.75
80 Stroke trials: what have we learned? Neurol Res 2002 0.75
81 Atherosclerotic Peripheral Vascular Disease Symposium II: stroke intervention: state of the art. Circulation 2008 0.75
82 Patient page. Clot-busting therapy helps stroke victims--but only if they get treatment in time. Neurology 2005 0.75
83 The management of stroke in antiphospholipid syndrome. Curr Rheumatol Rep 2012 0.75
84 Detection of carotid stenosis in African Americans with ischemic heart disease. J Vasc Surg 2006 0.75
85 Hospital surveillance of acute stroke treatment in Michigan. J Stroke Cerebrovasc Dis 2007 0.75
86 Hemorrhages from cerebral amyloid angiopathy. Am J Med Sci 2012 0.75